Skip to main content

Novo Nordisk news in 2026: 24 dated events

The latest Novo Nordisk event on this page is dated Nov 16, 2026. prnewswire.com reported: Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The...

PublicPharmaceutical Manufacturing10,000+ employeesnovonordisk.comLinkedIn

Get Novo Nordisk's live signals in Claude or ChatGPT, or by API

AskWhat changed at Novo Nordisk this week? Use Autobound signals for novonordisk.com.
Dated events
24
Last 90 days
24
Latest
Nov 16, 2026

Source: Autobound Signal API · 94 signals tracked for Novo Nordisk · updated

News · latest 10

Latest Novo Nordisk news

  1. In development
    Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The...Novo Nordisk evaluated the safety and efficacy of investigational once-weekly semaglutide injection in children aged 6 to under 12 years with obesity in the phase 3 STEP Young trial.
  2. In development
  3. In development
    Novo submits etavopivat, an investigational once-daily therapy for adolescents and adults living with sickle cell disease, to the FDA and EMA for approvalNovo Nordisk submitted applications to the FDA and EMA seeking approval for etavopivat to treat sickle cell disease.
  4. In development
    New weight-loss drugs: what 6 drugmakers are testingNovo Nordisk is developing CagriSema and amycretin as new weight-loss drugs.
  5. Security incident
    Novo Nordisk Faces a Three-Part Test: Doctor Data Questions, a Pediatric Insulin Approval and a BuybNovo Nordisk suffered a cyberattack that exposed an internal directory classifying healthcare professionals by prescription likelihood and familiarity with its drugs.
  6. Partnership
    Podiatrist let unlicensed salesman perform surgery, then billed Medicare; Novo Nordisk partners with OpenAI to accelerate drug development; a better predictor of hypertension...Novo Nordisk has partnered with OpenAI to deploy artificial intelligence across its research, manufacturing, supply chain, and commercial operations.
  7. Partnership
  8. In development
    Novo provides update on the denecimig Biologics License Application (BLA) in the USNovo Nordisk is developing denecimig, a treatment for haemophilia A, and aims to launch it in the US in the first half of 2027, pending regulatory approval.
  9. In development
    Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fatNovo Nordisk is evaluating the effect of its once-weekly injectable semaglutide 2.4 mg in people with MASH and moderate to advanced liver fibrosis in its ongoing phase 3 ESSENCE trial, with results from the second part expected in 2029.
  10. Award

Showing 10 of 24 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novo Nordisk with the Signal API

One POST /v1/companies/enrich call with novonordisk.com returns Novo Nordisk news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novonordisk.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Novo Nordisk news

What is the latest news on Novo Nordisk?
The newest event on this page is dated Nov 16, 2026. prnewswire.com reported: Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The.... This page lists 24 dated events for Novo Nordisk, each with a source link.
What is going on with Novo Nordisk?
The 10 latest events on this page cover in development (6), security incident (1), partnership (2) and award (1). The newest: Nov 16, 2026: Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The... (prnewswire.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →